Ms. Phillips et al., USING PHARMACIST CLINICAL INTERVENTION DATA FOR QUALITY IMPROVEMENT OF MEDICATION USE AND PHYSICIAN ASSESSMENT, The Joint Commission journal on quality improvement, 20(10), 1994, pp. 569-576
Background: Patient-specific intervention data are often used for drug
usage evaluation (DUE), but their use in physician assessment is less
often discussed. In response to the quality assurance department's re
quest, the pharmacy department at the Medical College of Georgia (Augu
sta) developed a database and a reporting system that supports quality
assessment of the medical staff, identifies housestaff education need
s, and directs efforts for improvement in medication use. The reportin
g system: In 1998 the comprehensive, concurrent screening of drug ther
apy by pharmacists formed the foundation of the hospital's DUE program
. Each month information from the pharmacy database is sorted with use
of a spreadsheet software program to generate medical department-leve
l reports and for use in physician reappointment. Identified performan
ce deficiencies can be used to educate individual prescribers and to d
evelop educational programs for the department or specialty areas. Fee
dback from the medical staff assessment is useful for pharmacist educa
tion, such as identifying newly reported indications and dosage regime
ns. Results: During the first six months after all pharmacists began p
articipating in the reporting program, a mean of 224 interventions wer
e recorded monthly. For the period January through June 1994, 400-550
interventions were recorded monthly. System improvements in medication
during the first year of implementation included hospitalwide guideli
nes for parenteral potassium and phosphate dosing and administration a
nd a renewed focus on patient allergies. Conclusion: Emphasis for use
of intervention data has shifted from identifying ''problem'' persons
to improving performance by identifying topics for corrective educatio
n and redesigning systems to promote positive patient outcomes.